ORGO logo

Organogenesis Holdings (ORGO) Shareholders Equity

Annual Shareholders Equity

$278.66 M
+$12.99 M+4.89%

31 December 2023

ORGO Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$278.55 M
+$15.05 M+5.71%

30 September 2024

ORGO Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ORGO Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.9%+0.6%
3 y3 years+96.5%+47.2%
5 y5 years+492.4%+2074.8%

ORGO Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+96.5%-0.0%+47.2%
5 y5 yearsat high+492.4%-0.0%+2074.8%
alltimeall time-7.2%+3357.3%-8.1%+3356.0%

Organogenesis Holdings Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$278.55 M(+5.7%)
June 2024
-
$263.50 M(-5.2%)
Mar 2024
-
$278.03 M(-0.2%)
Dec 2023
$278.66 M(+4.9%)
$278.66 M(+0.6%)
Sept 2023
-
$276.87 M(+2.1%)
June 2023
-
$271.28 M(+2.9%)
Mar 2023
-
$263.70 M(-0.7%)
Dec 2022
$265.67 M(+10.1%)
$265.67 M(+3.6%)
Sept 2022
-
$256.33 M(+0.8%)
June 2022
-
$254.38 M(+4.6%)
Mar 2022
-
$243.23 M(+0.8%)
Dec 2021
$241.34 M(+70.2%)
$241.34 M(+27.6%)
Sept 2021
-
$189.17 M(+5.7%)
June 2021
-
$178.92 M(+13.8%)
Mar 2021
-
$157.29 M(+10.9%)
Dec 2020
$141.81 M
$141.81 M(+116.6%)
Sept 2020
-
$65.47 M(+83.1%)
DateAnnualQuarterly
June 2020
-
$35.75 M(-11.3%)
Mar 2020
-
$40.30 M(-27.5%)
Dec 2019
$55.58 M(+18.2%)
$55.58 M(+334.0%)
Sept 2019
-
$12.81 M(-44.8%)
June 2019
-
$23.20 M(-28.8%)
Mar 2019
-
$32.56 M(-30.8%)
Dec 2018
$47.04 M(-649.9%)
$47.04 M(-84.5%)
Sept 2018
-
$303.17 M(+1.7%)
June 2018
-
$298.24 M(+0.1%)
Mar 2018
-
$297.88 M(-3581.9%)
Dec 2017
-$8.55 M(-102.9%)
-$8.55 M(-102.9%)
Sept 2017
-
$298.51 M(-0.7%)
June 2017
-
$300.63 M(+0.1%)
Mar 2017
-
$300.25 M(+0.0%)
Dec 2016
$300.11 M(<-9900.0%)
$300.11 M(<-9900.0%)
Sept 2016
-
-$30.70 K(+89.5%)
June 2016
-
-$16.20 K
Dec 2015
-$200.00
-

FAQ

  • What is Organogenesis Holdings annual stockholders equity?
  • What is the all time high annual shareholders equity for Organogenesis Holdings?
  • What is Organogenesis Holdings annual shareholders equity year-on-year change?
  • What is Organogenesis Holdings quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Organogenesis Holdings?
  • What is Organogenesis Holdings quarterly shareholders equity year-on-year change?

What is Organogenesis Holdings annual stockholders equity?

The current annual shareholders equity of ORGO is $278.66 M

What is the all time high annual shareholders equity for Organogenesis Holdings?

Organogenesis Holdings all-time high annual stockholders equity is $300.11 M

What is Organogenesis Holdings annual shareholders equity year-on-year change?

Over the past year, ORGO annual stockholders equity has changed by +$12.99 M (+4.89%)

What is Organogenesis Holdings quarterly stockholders equity?

The current quarterly shareholders equity of ORGO is $278.55 M

What is the all time high quarterly shareholders equity for Organogenesis Holdings?

Organogenesis Holdings all-time high quarterly stockholders equity is $303.17 M

What is Organogenesis Holdings quarterly shareholders equity year-on-year change?

Over the past year, ORGO quarterly stockholders equity has changed by +$1.68 M (+0.61%)